1. WALES BOWEL CANCER AUDIT (WCBA) MDT DATA FOR PATIENTS DIAGNOSED AUGUST 2010-JULY 2011 YSBYTY GWYNEDD (YG) MDT

2. Case Volume 2010-11 1WBCA Aug 2010-July 2011 - YG

3. Proportion of colon cancers being operated on by MDT 2010-11 2WBCA Aug 2010-July 2011 - YG

4. Proportion of rectal cancers being operated on by MDT 2010-11 3WBCA Aug 2010-July 2011 - YG

5. Percentage of elective/scheduled cases performed laparoscopically by MDT 2010-11 4WBCA Aug 2010-July 2011 - YG

6. Risk adjusted postoperative mortality (within 30 days) for patients having surgery (combined 3 year’s data for patients diagnosed April 2008-March 2010 and August 2010 to July 2011) 5WBCA Aug 2010-July 2011 - YG

7. Overall median length of stay after surgery reported by MDT performing surgery (in days), surgical access 2010-11 6WBCA Aug 2010-July 2011 - YG

8. Clinicopathological Dukes’ Stage of Operated Patients 2010-11 7WBCA Aug 2010-July 2011 - YG

9. Median lymph node harvest by MDT for colorectal major resections 2010-11 8WBCA Aug 2010-July 2011 - YG

10. Use of radiotherapy by MDT in patients having elective resective surgery for rectal cancer 2010-11 9WBCA Aug 2010-July 2011 - YG

11. Proportion of elective major resected rectal cases seen by an MDT, with CMI in a 3 year period (where CMI status is recorded) 10WBCA Aug 2010-July 2011 - YG

12. Major resection procedure rates for elective rectal cases (2009/10 and 2010/11 combined) 11WBCA Aug 2010-July 2011 - YG

13. NSAG clinical indicators 12WBCA Aug 2010-July 2011 - YG 1. All elective cases seen by specialist nurse before surgery. 2. Review by MDT of all cases. 3. Abdominal CT scan before surgery in all cases (elective and emergency) excluding polypectomies and stents. 4.Pelvic MRI scan (or EUS) carried out before all elective rectal cancer resections. 5.Report the presence or absence of non-peritonealised (circumferential) margin involvement in all rectal cancer resections (except local resections). 6.The median number of lymph nodes examined in resection specimens for colorectal cancer should be at least 12 (except local resections). Attainment of at least 80% (the minimum threshold) is indicated by green shading for indicators 1-5. For indicator 6 a median harvest of 12 or greater is shaded green. Those below the minimum level are shaded red.

14. 2010/11 data CNS (elective cases) MDT (all) CT (all op excl stents & polyps) MRI (all rectal elective resections) CMI recorded (major rectal resections) Median no. nodes (major resections) YG91%100%98%89%87%10 YGC99%100%96%84%100%17 YMH100%99%79%85%96%19 POW & NPT93%98% 88%100%15.5 SWANSEA91%98%92%66%86%17 WWG & PPH92%100%86% 54%12 WITHYBUSH83%96%94%92%91%12 BRONGLAIS93%98%94%100% 10 NHH96%98%95%93%100%16 RGH98%99%96%80%100%12.5 CARDIFF93%98%96%91%94%15 RGLH73%99%83%95%100%11 PCH98%95%75%86%81%12 ALL WALES93%99%92%85%92%14 13WBCA Aug 2010-July 2011

15. WBCA Aug 2010-July 2011 - YG14 Further information and feedback Full report on Cancer NSAG website http://howis.wales.nhs.uk/sites3/p age.cfm?orgid=322 http://howis.wales.nhs.uk/sites3/p age.cfm?orgid=322 For audit queries and feedback contact clinical leads, information leads, analysts or cancer NSAG colorectal group representatives via Louise.Carrington@wales.nhs.uk Louise.Carrington@wales.nhs.uk For Network resources to help improve outcomes contact: SOUTH WALES CANCER NETWORK (SWCN) Hywel.Morgan@Wales.NHS.UK Tom.Crosby@Wales.NHS.UK NORTH WALES CANCER NETWORK (NWCN) Damian.Heron@Wales.NHS.UK Caroline.Williams@Wales.NHS.UK Cancer NSAG colorectal group